The Trump administration is halting more than $1 billion in federal Medicaid payments to California and Minnesota until the states take more steps to investigate questionable claims, federal health officials said on Tuesday.
Why it matters: The moves continue a series of freezes to blue states' funding as part of the administration's crackdown on fraud.
The Trump administration formally laid the groundwork Monday to weigh immigrants' use of programs like Medicaid and CHIP in determining whether they should get permanent residency.
Why it matters: The policy shift could discourage immigrant families from seeking health coverage if it could put their legal status at risk, public health groups warn.
The FDA said Monday it still thinks Taylor Farms lettuce is likely behind a Cyclospora outbreak, even after pulling back earlier test results linking the produce to the parasite.
Why it matters: Tracking the source of the diarrhea-causing illness presents a steep challenge for health officials and suppliers, while news of a false positive risks confusing consumers about which recalled products to avoid.
Artificial intelligence is dramatically speeding up drug development — and a proprietary survey shows how it's priming a bigger automation push that's changing the trajectory of early stage pharma research.
Why it matters: The TD Cowen survey of 80 biopharma leaders and insiders finds AI is compressing drug developers' preclinical costs and timelines by as much as 70%.
